| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |